{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pfam:PF14769",
      "entity_text" : "clamp",
      "entity_type" : "family"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P01241",
      "entity_text" : "growth hormone",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Before the SHC procedure (~ 2.25 h), octreotide (30 ng/kg.min -1) was infused to suppress endogenous pancreatic hormone secretion, and infusions of glucagon (1 ng/kg.min -1) and growth hormone (3 ng/kg.min -1) were started to restore basal plasma levels of these hormones (pancreatic clamp).",
  "reading_complete" : "2020-07-28T11:26:48Z",
  "reader_type" : "machine",
  "reading_started" : "2020-07-28T11:21:12Z",
  "trigger" : "restore",
  "evidence" : [ "growth hormone (3 ng/kg.min -1 ) were started to restore basal plasma levels of these hormones (pancreatic clamp" ],
  "pmc_id" : "3781504",
  "score" : 0
}